BNP Paribas Financial Markets’s Outlook Therapeutics OTLK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $885 | Sell |
553
-393
| -42% | -$629 | ﹤0.01% | 4339 |
|
2025
Q1 | $1.15K | Sell |
946
-2,004
| -68% | -$2.45K | ﹤0.01% | 4216 |
|
2024
Q4 | $5.58K | Sell |
2,950
-70
| -2% | -$132 | ﹤0.01% | 4070 |
|
2024
Q3 | $16.1K | Buy |
3,020
+2,330
| +338% | +$12.4K | ﹤0.01% | 3039 |
|
2024
Q2 | $5.09K | Sell |
690
-3,815
| -85% | -$28.2K | ﹤0.01% | 3087 |
|
2024
Q1 | $53.8K | Buy |
4,505
+186
| +4% | +$2.22K | ﹤0.01% | 2896 |
|
2023
Q4 | $34K | Sell |
4,319
-21,773
| -83% | -$172K | ﹤0.01% | 2903 |
|
2023
Q3 | $115K | Buy |
26,092
+24,070
| +1,190% | +$106K | ﹤0.01% | 2614 |
|
2023
Q2 | $70.4K | Sell |
2,022
-1,222
| -38% | -$42.5K | ﹤0.01% | 2755 |
|
2023
Q1 | $70.7K | Buy |
3,244
+2,377
| +274% | +$51.8K | ﹤0.01% | 2751 |
|
2022
Q4 | $18.7K | Buy |
867
+364
| +72% | +$7.86K | ﹤0.01% | 2891 |
|
2022
Q3 | $12.3K | Sell |
503
-789
| -61% | -$19.2K | ﹤0.01% | 3445 |
|
2022
Q2 | $26.4K | Buy |
1,292
+821
| +174% | +$16.7K | ﹤0.01% | 3031 |
|
2022
Q1 | $16.8K | Sell |
471
-482
| -51% | -$17.2K | ﹤0.01% | 3175 |
|
2021
Q4 | $25.9K | Buy |
953
+151
| +19% | +$4.11K | ﹤0.01% | 3186 |
|
2021
Q3 | $34.8K | Buy |
802
+633
| +375% | +$27.5K | ﹤0.01% | 2990 |
|
2021
Q2 | $8.4K | Buy |
+169
| New | +$8.4K | ﹤0.01% | 3160 |
|